2014-03-17 19:05:01 - EpiCast Report: Diabetic Neuropathy - Epidemiology Forecast to 2022 - a new market research report on companiesandmarkets.com
The total prevalent cases of diabetic neuropathy in the seven major markets (7MM) â the US, France, Germany, Italy, Spain, UK and Japan â is expected to increase steadily from 13.84 million in 2012 to 19.78 million by 2022.
Out of the 7MM, the US will have the highest number of prevalent diabetic neuropathy cases during the forecast period, with a share of approximately 45%. Currently, the condition affects an estimated 50% of patients with diabetes worldwide and is one of the leading causes of morbidity, often causing foot ulcerations or the need for amputation.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.